Confluent Surgical gets FDA panel date
This article was originally published in The Gray Sheet
Executive Summary
Agency's neurological devices advisory panel will meet May 14 in Gaithersburg, Md., to make recommendations on the firm's DuralSeal Xact sealant system PMA application. The company seeks approval for the device as an adjunct to sutured dural repair to obtain watertight closure during spine surgery